Tavo Biotherapeutics
Tavo Biotherapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
About Tavo Biotherapeutics
Tavo Biotherapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Tavo Biotherapeutics develops novel ophthalmic therapies focused on treating glaucoma and retinal diseases by targeting the autonomic nervous system to reduce intraocular pressure and provide neuroprotection. Their lead candidate, TAV-001, is a topical therapy in clinical trials designed to modulate disease progression at its biological root causes.
Explore Tavo Biotherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.